Business Context and Reporting Period
Company: On Assignment, Inc. (Note: Input metadata listed "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2010
Business Overview: A diversified professional staffing firm operating in four segments: Life Sciences, Healthcare, Physician, and IT and Engineering. The company provides contract professionals, contract-to-permanent placements, and direct placements.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2010 | Six Months Ended June 30, 2010 |
|---|---|---|
| Revenues | $104.5 million | $200.8 million |
| Gross Profit | $35.3 million (33.8% margin) | $66.1 million (32.9% margin) |
| Operating Income | $3.3 million | $4.3 million |
| Net Income | $0.9 million | $0.6 million |
| Diluted EPS | $0.03 | $0.02 |
| Cash and Equivalents | $30.5 million (as of June 30, 2010) | |
| Working Capital | ||
| Long-Term Debt | $77.9 million | |
| Total Assets |
Cash Flow (Six Months): Net cash provided by operating activities was $14.5 million. Net cash used in investing activities was $8.0 million (primarily for the Cambridge acquisition). Net cash used in financing activities was $0.5 million.
Material Changes vs. Prior Period
- Revenue Trends:
- Q2 2010 vs. Q2 2009: Consolidated revenue increased 2.6% ($2.6 million). Growth was driven by the IT and Engineering segment (+26.8%) and Life Sciences (+12.1%), offset by declines in Healthcare (-17.0%) and Physician (-21.0%).
- YTD 2010 vs. YTD 2009: Consolidated revenue decreased 8.2% ($17.9 million). Significant declines in Healthcare (-30.8%) and Physician (-17.3%) outweighed growth in IT and Engineering (+9.0%) and Life Sciences (+0.9%).
- Profitability: Gross margin expanded to a record 33.8% in Q2 2010 compared to 32.8% in Q2 2009, driven by margin expansion in Healthcare and Physician segments and a reduced mix of low-margin Nurse Travel revenue.
- Acquisitions: The company acquired The Cambridge Group Ltd. in April 2010 for $5.4 million cash plus up to $2.3 million in earn-outs. This contributed $2.1 million to Q2 revenues.
- Segment Performance:
- Healthcare: Nurse Travel revenue dropped significantly due to a 43.8% decrease in the average number of nurses on assignment.
- Physician: Revenue declined due to reduced elective procedures and lower patient census linked to economic conditions.
- IT & Engineering: Revenue growth attributed to increased capital spending by clients and a 34.6% increase in contract professionals on assignment.
Guidance, Outlook, and Risks
- Outlook: Management expects demand to increase in the second and third quarters due to seasonality. The company anticipates an economic recovery throughout 2010 for most reporting units, excluding Nurse Travel and Physician.
- Goodwill Impairment Risk: The company performed a Step 1 goodwill impairment test. While the Physician segment's revenue forecast was revised down by 3%, the fair value of the reporting unit still exceeded its carrying value by 13.6%. However, management noted that fair value estimates are sensitive to discount rate changes (less than 200 basis points) or cash flow declines (less than 10%).
- Stock Price Sensitivity: A sustained decline in stock price resulting in market capitalization significantly below book value could trigger a goodwill impairment charge.
- Debt Covenants: The company is in compliance with all financial covenants under its credit facility and expects to maintain compliance for the next 12 months.
- Subsequent Event: On July 19, 2010, the company acquired Sharpstream Holdings, Ltd. for $7.2 million cash plus a $1.4 million earn-out.
Investor Verification Checklist
- Revenue Mix Shift: Verify the sustainability of the margin expansion given the significant decline in the Healthcare and Physician segments.
- Goodwill Valuation: Monitor the sensitivity of the goodwill impairment test, particularly regarding the Physician segment and the company's stock price relative to book value.
- Debt Obligations: Confirm the status of the $77.9 million term loan and the impact of the 3.0% LIBOR floor on interest expense.
- Acquisition Integration: Assess the performance of the Cambridge Group acquisition and the subsequent Sharpstream acquisition against earn-out targets.
- Seasonality: Evaluate whether Q2 results are indicative of a broader trend or primarily driven by seasonal demand patterns.